Notch1 Silencing in Tumor-Macrophage Interactions
Corresponding Organization :
Other organizations : Albert Einstein College of Medicine, National Cancer Institute, Yeshiva University, NYU Langone Health, Frederick National Laboratory for Cancer Research, Protein Express (United States)
Variable analysis
- SiRNA treatment (AllStars Neg. Control siRNA and On-target plus human Notch1 siRNA smartpool)
- Notch1 protein expression level (measured by western blotting)
- Interaction between tumor cells and macrophages (observed by live cell imaging)
- Cell line (tdtomato MDA-MB-231 SORE6>GFP tumor cells)
- Transfection method (Nucleofector Kit V from Lonza)
- SiRNA concentration (10 µl of 20 µM siRNA stock solution)
- Incubation time (48 h for siRNA transfection, 36 h for subsequent experiments)
- Positive control: Notch1 siRNA
- Negative control: AllStars Neg. Control siRNA
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!